Vlad Coric

Insider Reports History

Entity
Individual
Location
C/O Biohaven Pharmaceutical Holding Comp, 234 Church Street, New Haven, CT
Signature
/s/ George Clark, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Vlad Coric:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Biohaven Pharmaceutical Holding Co Ltd. Chief Executive Officer, Director Common Shares 831K $123M $148.50 Oct 3, 2022 Direct
Biohaven Ltd. Chief Executive Officer, Director Common Shares 1.79M $85M $47.50 Oct 2, 2024 Direct
Biohaven Pharmaceutical Holding Co Ltd. Chief Executive Officer, Director Common Shares 517K $76.8M $148.50 Oct 3, 2022 By: The Vladimir Coric Marital Trust
Biohaven Pharmaceutical Holding Co Ltd. Chief Executive Officer, Director Common Shares 498K $74M $148.50 Oct 3, 2022 By 401(K) Plan
Biohaven Ltd. Chief Executive Officer, Director Common Shares 862K $40.9M $47.50 Oct 2, 2024 By: The Vlad Coric Family Trust
Biohaven Ltd. Chief Executive Officer, Director Common Shares 407K $19.3M $47.50 Oct 2, 2024 By: The Vladimir Coric Marital Trust
Biohaven Ltd. Chief Executive Officer, Director Common Shares 110K $5.2M $47.50 Oct 2, 2024 By: 401(K) Plan
Revance Therapeutics, Inc. Director Common Stock 20.8K $79K $3.80 May 1, 2024 Direct
Biohaven Ltd. Chief Executive Officer, Director Stock Options (Right to buy) 275K Jan 2, 2024 Direct
Revance Therapeutics, Inc. Director Stock Option (Right to buy) 23.5K May 1, 2024 Direct
Biohaven Pharmaceutical Holding Co Ltd. Chief Executive Officer, Director Common Shares 0 $148.50 Oct 3, 2022 By: The Vladimir Coric Family Trust
Biohaven Pharmaceutical Holding Co Ltd. Chief Executive Officer, Director Restricted Share Unit Award 0 Oct 3, 2022 Direct
Biohaven Pharmaceutical Holding Co Ltd. Chief Executive Officer, Director Stock Options (Right to Buy) 0 Oct 3, 2022 Direct

Insider Reports Filed by Vlad Coric

Symbol Company Period Transactions Value $ Form Type Date Filed Role
BHVN Biohaven Ltd. Oct 2, 2024 1 $1M 4 Oct 3, 2024 Chief Executive Officer, Director
RVNC Revance Therapeutics, Inc. May 1, 2024 2 $0 4 May 3, 2024 Director
BHVN Biohaven Ltd. Apr 22, 2024 1 $5M 4 Apr 23, 2024 Chief Executive Officer, Director
BHVN Biohaven Ltd. Apr 5, 2024 3 $0 4 Apr 5, 2024 Chief Executive Officer, Director
BHVN Biohaven Ltd. Mar 8, 2024 3 $0 4 Mar 8, 2024 Chief Executive Officer, Director
BHVN Biohaven Ltd. Jan 8, 2024 3 $0 4 Jan 10, 2024 Chief Executive Officer, Director
BHVN Biohaven Ltd. Jan 2, 2024 1 $0 4 Jan 4, 2024 Chief Executive Officer, Director
BHVN Biohaven Ltd. Nov 2, 2023 1 $0 4 Nov 6, 2023 Chief Executive Officer, Director
BHVN Biohaven Ltd. Oct 5, 2023 2 $10M 4 Oct 10, 2023 Chief Executive Officer, Director
RVNC Revance Therapeutics, Inc. May 3, 2023 2 $0 4 May 5, 2023 Director
RVNC Revance Therapeutics, Inc. Mar 1, 2023 2 $0 4 Mar 3, 2023 Director
RVNC Revance Therapeutics, Inc. Mar 1, 2023 0 $0 3 Mar 3, 2023 Director
BHVN Biohaven Ltd. Oct 31, 2022 1 $412K 4 Nov 1, 2022 Chief Executive Officer, Director
BHVN Biohaven Ltd. Oct 28, 2022 2 $2.11M 4 Oct 31, 2022 Chief Executive Officer, Director
BHVN Biohaven Ltd. Oct 25, 2022 1 $8.96M 4 Oct 26, 2022 Chief Executive Officer, Director
BHVN Biohaven Ltd. Oct 5, 2022 9 $5.01M 4 Oct 6, 2022 Chief Executive Officer, Director
BHVN Biohaven Ltd. Oct 3, 2022 1 $0 4/A Oct 12, 2022 Chief Executive Officer, Director
BHVN Biohaven Pharmaceutical Holding Co Ltd. Oct 3, 2022 26 -$137M 4 Oct 3, 2022 Chief Executive Officer, Director
BHVN Biohaven Ltd. Sep 22, 2022 0 $0 3 Sep 28, 2022 Chief Executive Officer, Director
BHVN Biohaven Pharmaceutical Holding Co Ltd. Jan 6, 2022 8 -$1.32M 4 Jan 7, 2022 Chief Executive Officer, Director
BHVN Biohaven Pharmaceutical Holding Co Ltd. Dec 31, 2021 4 $0 5 Feb 11, 2022 Chief Executive Officer, Director
BHVN Biohaven Pharmaceutical Holding Co Ltd. Nov 25, 2021 3 -$586K 4 Nov 26, 2021 Chief Executive Officer, Director
AKLI Social Capital Suvretta Holdings Corp. I Jun 29, 2021 0 $0 3 Jun 29, 2021 Director